NEXT

Litigation Daily

Shout-Out: Latham Litigators Kill Drug Price Disclosure Rule

Litigators from Latham & Watkins persuaded a federal judge in Washington, D.C. to void a HHS rule that would have required drugmakers in ads to disclose the list price of a 30-day supply of the medicine.
2 minute read

Delaware Law Weekly

5 State AGs Oppose Bankruptcy Stay in Their Opioid Cases Against Insys

A bankruptcy judge in Delaware is set to hear arguments Tuesday over whether to halt 166 government lawsuits against Insys Therapeutics Inc. over the opioid crisis.
4 minute read

The Recorder

No Clinical Trial, No Injunction in Biopharma Trade Secret Case

Fenwick lawyers persuade Colorado judge that without a drug in clinical trials, there's no rush to enjoin nine employees from continuing to work at Loxo Oncology Inc.
3 minute read

Law.com

Florida AG, Other Gov't Plaintiffs Object to Insys Bankruptcy Procedure

Insys has filed a motion to estimate the total costs of about 1,000 lawsuits brought against it over the opioid crisis ahead of a planned sale of its assets.
5 minute read

Law.com

Judge Grants More Time for a 'Novel Idea' to Settle Opioid Cases

At a Tuesday hearing, plaintiffs' attorneys who proposed a "negotiation class" to settle all the opioid lawsuits agreed to give more time for objections, some of which have come from distributors, pharmacies and state attorneys general.
6 minute read

The Legal Intelligencer

FDA Hearing on Cannabis Products—CBD Takes Center Stage

While the president and Congress gave hemp the go-ahead, it is now on the regulators to take the next step. The FDA has authority to regulate cannabis-derived compounds, including CBD, under the Federal Food, Drug, and Cosmetic Act. So far, though, the FDA has not done much regulating in regards to CBD.
7 minute read

New York Law Journal

NY Judge Allows Opioid Claims to Go Forward Against Sacklers

Suffolk County Supreme Court Judge Jerry Garguilo found two cities and 31 counties could move forward on their claims against the Sacklers, who are current and former directors of opioid manufacturer Purdue Pharma.
4 minute read

New York Law Journal

Shkreli Settles Disputes With His Former Company, Firm Says

A spokeswoman Retrophin confirmed Thursday that it had settled a lawsuit that Shkreli filed last month from prison, where he is serving a seven-year sentence for defrauding investors in two hedge funds he created.
2 minute read

The Recorder

Gilead Chooses White & Case for Antitrust Class Action

Co-defendants Bristol-Myers Squibb turns to Arnold & Porter, while J&J calls on Drinker Biddle and Japan Tobacco tabs Holland & Knight.
2 minute read

Law.com

Oklahoma's Governor and 9 Cities Raise Red Flags Over Opioid Settlement

On Monday, a judge said he would bring in retired Oklahoma Supreme Court Judge Steven Taylor to resolve concerns raised by the governor and nine cities over an $85 million deal the attorney general reached with Teva Pharmaceuticals.
5 minute read

Resources

  • The Power of Online Reputation Management For Attorneys: A Critical Tool For Law Firms in 2025

    Brought to you by Erase.com

    Download Now

  • The Role of Evolving Support Structures in Optimizing Legal Talent

    Brought to you by BigHand

    Download Now

  • Corporate Monitorship Advisory Services

    Brought to you by HaystackID

    Download Now

  • AI-Powered Deposition and Medical Record Summaries: Low Risk, High Reward

    Brought to you by Parrot

    Download Now